Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease
E. Benedetti(University of Illinois Chicago), Sara Galimberti(University of Pisa), Fabrizio Mavilia(Azienda Ospedaliera Universitaria Pisana), Enrico Capochiani(University of Pisa), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Ginevra Traverso(Azienda Ospedaliera Universitaria Pisana), Emilia Bramanti(Institute for the Chemistry of OrganoMetallic Compounds), Giulia Cervetti(University of Pisa), Salvatore Massimo Stella, Claudia Baratè(Azienda Ospedaliera Universitaria Pisana), Ilaria Bertaggia(Azienda Usl Toscana Centro), Riccardo Morganti(Azienda Ospedaliera Universitaria Pisana), Valentina Guerri(University of Pisa)
Cited by 1
Related Papers
Isolated Single-Cycle Attosecond Pulses
|Science|2006|1.7k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
|Blood|2003|407
Controlling Two-Center Interference in Molecular High Harmonic Generation
|Physical Review Letters|2005|371
Qualitative and quantitative analysis of wood samples by Fourier transform infrared spectroscopy and multivariate analysis
|Carbohydrate Polymers|2010|369